LncRNA CARMN overexpression promotes prognosis and chemosensitivity of triple negative breast cancer via acting as miR143-3p host gene and inhibiting DNA replication

BACKGROUND: Triple negative breast cancer (TNBC) is a subtype of breast cancer with poor prognosis and lack of effective treatment target. Here we screened differentially expressed lncRNAs through bioinformatics analysis and identified CARMN as a downregulated lncRNA which is lowest expressed in TNB...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Exp Clin Cancer Res
Autors principals: Sheng, Xiaonan, Dai, Huijuan, Du, Yueyao, Peng, Jing, Sha, Rui, Yang, Fan, Zhou, Liheng, Lin, Yanping, Xu, Shuguang, Wu, Yifan, Yin, Wenjin, Lu, Jinsong
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8220716/
https://ncbi.nlm.nih.gov/pubmed/34162418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-021-02015-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars